Terms: = Brain cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
142 results:
1. The emerging role of fatty acid binding protein 7 (FABP7) in cancers.
George Warren W; Osborn M; Yates A; O'Sullivan SE
Drug Discov Today; 2024 May; 29(5):103980. PubMed ID: 38614160
[TBL] [Abstract] [Full Text] [Related]
2. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target.
Ren LK; Lu RS; Fei XB; Chen SJ; Liu P; Zhu CH; Wang X; Pan YZ
J Cancer Res Clin Oncol; 2024 Mar; 150(3):127. PubMed ID: 38483604
[TBL] [Abstract] [Full Text] [Related]
3. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/erk signalling axis.
Wang Y; Wang B; Cao W; Xu X
Biochem Biophys Res Commun; 2024 Apr; 703():149665. PubMed ID: 38359612
[TBL] [Abstract] [Full Text] [Related]
4. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
Nie J; Dang S; Zhu R; Lu T; Zhang W
Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
[TBL] [Abstract] [Full Text] [Related]
5. Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics.
Sokolov D; Sharda N; Banerjee A; Denisenko K; Basalious EB; Shukla H; Waddell J; Hamdy NM; Banerjee A
Curr Pharm Des; 2024; 30(1):31-47. PubMed ID: 38151840
[TBL] [Abstract] [Full Text] [Related]
6. A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma.
Xing B; Lei Z; Wang Z; Wang Q; Jiang Q; Zhang Z; Liu X; Qi Y; Li S; Guo X; Liu Y; Li X; Shu K; Zhang H; Bartsch JW; Nimsky C; Huang Y; Lei T
Neuro Oncol; 2024 Jan; 26(1):137-152. PubMed ID: 37555799
[TBL] [Abstract] [Full Text] [Related]
7. Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment.
Guo T; Wu C; Zhou L; Zhang J; Wang W; Shen Y; Zhang L; Niu M; Zhang X; Yu R; Liu X
J Transl Med; 2023 Aug; 21(1):532. PubMed ID: 37550679
[TBL] [Abstract] [Full Text] [Related]
8. [Lactate-induced up-regulation of PLEKHA4 promotes proliferation and apoptosis of human glioma cells].
Ye J; Xu W; Xi B; Wang N; Chen T
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1071-1080. PubMed ID: 37488789
[TBL] [Abstract] [Full Text] [Related]
9. Chronic stress accelerates glioblastoma progression via DRD2/erk/β-catenin axis and Dopamine/erk/TH positive feedback loop.
Wang Y; Wang X; Wang K; Qi J; Zhang Y; Wang X; Zhang L; Zhou Y; Gu L; Yu R; Zhou X
J Exp Clin Cancer Res; 2023 Jul; 42(1):161. PubMed ID: 37415171
[TBL] [Abstract] [Full Text] [Related]
10. INHBB promotes tumor aggressiveness and stemness of glioblastoma via activating EGFR signaling.
Yang X; Jia Q; Zou Z; Liu X; Li X; Chen H; Ma H; Chen L
Pathol Res Pract; 2023 May; 245():154460. PubMed ID: 37116368
[TBL] [Abstract] [Full Text] [Related]
11. Development of Prognostic Indicator Based on AU-Rich Elements-Related Genes in Glioblastoma.
Chen X; Xu Y; Wang M; Ren C
World Neurosurg; 2023 Jul; 175():e601-e613. PubMed ID: 37030479
[TBL] [Abstract] [Full Text] [Related]
12. Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis.
Goenka A; Song X; Tiek D; Iglesia RP; Lu M; Zeng C; Horbinski C; Zhang W; Hu B; Cheng SY
Neuro Oncol; 2023 Sep; 25(9):1592-1604. PubMed ID: 36988488
[TBL] [Abstract] [Full Text] [Related]
13. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
14. Rab32 promotes glioblastoma migration and invasion via regulation of erk/Drp1-mediated mitochondrial fission.
Chen P; Lu Y; He B; Xie T; Yan C; Liu T; Wu S; Yeh Y; Li Z; Huang W; Zhang X
Cell Death Dis; 2023 Mar; 14(3):198. PubMed ID: 36922509
[TBL] [Abstract] [Full Text] [Related]
15. Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/erk signaling pathway.
Liu X; Hu Y; Xue Z; Zhang X; Liu X; Liu G; Wen M; Chen A; Huang B; Li X; Yang N; Wang J
J Transl Med; 2023 Feb; 21(1):147. PubMed ID: 36829235
[TBL] [Abstract] [Full Text] [Related]
16. BMAL1 promotes colorectal cancer cell migration and invasion through erk- and JNK-dependent c-Myc expression.
Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
[TBL] [Abstract] [Full Text] [Related]
17. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies.
Jin J; Duan J; Du L; Xing W; Peng X; Zhao Q
Front Immunol; 2022; 13():1027756. PubMed ID: 36505409
[TBL] [Abstract] [Full Text] [Related]
18. BDNF and its signaling in cancer.
Malekan M; Nezamabadi SS; Samami E; Mohebalizadeh M; Saghazadeh A; Rezaei N
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2621-2636. PubMed ID: 36173463
[TBL] [Abstract] [Full Text] [Related]
19. Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma.
Fan Y; Gao Z; Xu J; Wang H; Guo Q; Xue H; Zhao R; Guo X; Li G
Front Immunol; 2022; 13():986615. PubMed ID: 36159816
[TBL] [Abstract] [Full Text] [Related]
20. Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.
Leskoske KL; Garcia-Mansfield K; Sharma R; Krishnan A; Rusert JM; Mesirov JP; Wechsler-Reya RJ; Pirrotte P
J Proteome Res; 2022 Sep; 21(9):2124-2136. PubMed ID: 35977718
[TBL] [Abstract] [Full Text] [Related]
[Next]
